Serious side effects should be reported to the FDA MedWatch program in addition to discussing them with your healthcare provider
First cardiovascular safety trial to demonstrate that a GLP-1R agonist reduces MACE and microvascular (including renal) events in patients with T2DM and high cardiovascular risk
By acting as an agonist to these hormones, Tirzepatide helps manage appetite and create a feeling of fullness after eating, which leads to reduced food intake and greater satiety
Both are typically used long-term
Patients complete a medical questionnaire, have their responses reviewed by a licensed provider, and receive a prescription for GLP-1s in a fraction of the time it would take to go through a traditional clinic
Foods containing healthy fats, such as salmon, herring, avocado, and olives, are great for raising the hormones levels